NASDAQ$TREE
LendingTree Inc · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Demonstrated clear evidence of increasing momentum with consumer segment recovery gaining momentum and home and insurance remaining strong.
LendingTree reported a strong second quarter, with consolidated revenue of $270.0 million and GAAP net income from continuing operations of $9.8 million, or $0.71 per diluted share. The company's financial performance is rebounding, driven by recovery in the Consumer segment and sustained strength in Home and Insurance.
- Consolidated revenue reached $270.0 million.
- GAAP net income from continuing operations was $9.8 million, or $0.71 per diluted share.
- Variable marketing margin was $98.4 million.
- Adjusted net income per share was $0.76.
Headline financials
Revenue & EPS history
LendingTree · Revenue · Quarterly
$270M
Revenue by segment
LendingTree · $270M total across 3 segments · Q2 2021
- Home$105M+41.6%38.9%
- Insurance$89.3M+22.5%33.1%
- Consumer$75.7M+104.0%28.0%
Forward guidance
LendingTree issued an outlook for the third quarter 2021, expecting Home to remain resilient, Consumer to continue its recovery, and Insurance to see top-line growth with modestly contracting segment margins. Non-variable costs are expected to increase materially.
Tailwinds
- Home to remain resilient, generally extending the trends we observed in Q2.
- In Consumer, we expect the elevated pace of recovery in key products to continue.
- Top-line growth should continue in Insurance.
- Segment margins continue to contract modestly to the mid-thirties as a percent of revenue.
- Revenue: $285 - $298 million
Headwinds
- Difficulty in forecasting the recovery of our Consumer segment
- Effects of volatile interest rate movements in our Home segment
- Segment margins continue to contract modestly to the mid-thirties as a percent of revenue.
- Non-variable costs are expected to increase materially over Q2 as we added 115 employees in Q2 and continue to add staffing in Q3 to support key initiatives, particularly our Medicare agency.
- Adjusted EBITDA: $35 - $40 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
+2.9%
Avg return
Earnings day
-2.1%
Avg return
5 days after
-3.3%
Avg return
30 days after
59%
38 / 64 earnings
Positive
+41.7%
Q2 2015
Best reaction
-22.2%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -21.9% | -20.0% | -23.3% | |
| Q4 2025 | +14.2% | +13.7% | +8.0% | |
| Q3 2025 | +2.5% | -9.7% | -11.2% | |
| Q1 2025 | -20.3% | -30.7% | -35.3% | |
| Q4 2024 | +22.5% | +2.2% | +14.1% | |
| Q3 2024 | -22.2% | -18.8% | -23.8% | |
| Q2 2024 | +6.3% | +0.4% | +9.4% | |
| Q1 2024 | +28.2% | +32.3% | +19.1% | |
| Q4 2023 | +3.2% | +16.6% | +23.5% | |
| Q3 2023 | +35.5% | +45.3% | +59.9% | |
| Q2 2023 | -13.8% | -17.1% | -33.8% | |
| Q1 2023 | -20.9% | -20.2% | -20.3% | |
| Q4 2022 | -11.6% | -11.9% | -30.4% | |
| Q3 2022 | +11.5% | +10.1% | +10.9% | |
| Q2 2022 | -6.3% | -11.5% | -28.6% | |
| Q1 2022 | -6.0% | -18.5% | -19.6% | |
| Q4 2021 | +20.6% | -19.0% | -1.1% | |
| Q3 2021 | +10.7% | +1.5% | -18.3% | |
| Q2 2021 | -3.7% | -10.6% | -16.4% | |
| Q1 2021 | -16.2% | -20.4% | -16.7% | |
| Q4 2020 | -18.5% | -17.8% | -37.6% | |
| Q3 2020 | -16.2% | -12.1% | -29.8% | |
| Q2 2020 | -7.0% | -7.2% | -14.9% | |
| Q1 2020 | -6.2% | -0.4% | +15.9% | |
| Q4 2019 | -15.1% | -19.2% | -41.1% | |
| Q3 2019 | +11.1% | +19.3% | +11.4% | |
| Q2 2019 | -15.7% | -21.0% | -27.8% | |
| Q1 2019 | +1.8% | +4.2% | +1.6% | |
| Q4 2018 | +0.2% | +0.7% | +8.5% | |
| Q3 2018 | +30.0% | +26.8% | +29.1% | |
| Q2 2018 | -3.0% | -2.9% | -2.4% | |
| Q1 2018 | -20.3% | -15.8% | -15.4% | |
| Q4 2017 | -8.6% | -5.8% | -4.5% | |
| Q3 2017 | +20.3% | +21.0% | +35.9% | |
| Q2 2017 | +17.8% | +22.0% | +21.2% | |
| Q1 2017 | +12.0% | +14.8% | +25.2% | |
| Q4 2016 | +10.0% | +5.6% | +6.0% | |
| Q3 2016 | -14.8% | -11.7% | +18.1% | |
| Q2 2016 | +5.7% | +4.0% | +5.4% | |
| Q1 2016 | -6.8% | — | — | |
| Q4 2015 | +19.4% | — | — | |
| Q3 2015 | +26.5% | — | — | |
| Q2 2015 | +41.7% | — | — | |
| Q1 2015 | -10.9% | — | — | |
| Q4 2014 | +18.4% | — | — | |
| Q3 2014 | +30.1% | — | — | |
| Q2 2014 | +4.5% | — | — | |
| Q1 2014 | -18.2% | — | — | |
| Q4 2013 | +2.3% | — | — | |
| Q3 2013 | +12.0% | — | — | |
| Q2 2013 | +24.1% | — | — | |
| Q1 2013 | -3.3% | — | — | |
| Q4 2012 | +15.1% | — | — | |
| Q3 2012 | +10.4% | — | — | |
| Q2 2012 | +3.5% | — | — | |
| Q1 2011 | +1.2% | — | — | |
| Q1 2012 | +3.2% | — | — | |
| Q4 2011 | +3.2% | — | — | |
| Q3 2011 | -0.4% | — | — | |
| Q3 2010 | -0.4% | — | — | |
| Q2 2011 | +3.5% | — | — | |
| Q2 2010 | +3.5% | — | — | |
| Q4 2010 | +3.5% | — | — | |
| Q1 2010 | +2.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro